These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4180290)

  • 1. The nasal and bronchopulmonary effects of oxymetazoline and KB227.
    Carrillo L; Kishimoto T; Aviado DM
    Ann Otol Rhinol Laryngol; 1969 Apr; 78(2):415-24. PubMed ID: 4180290
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-receptor-mediated modulation of transmitter release from central noradrenergic neurones.
    Starke K; Montel H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(1):53-60. PubMed ID: 4127206
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of different preparations of nasal decongestants on ciliary beat frequency in vitro.
    Deitmer T; Scheffler R
    Rhinology; 1993 Dec; 31(4):151-3. PubMed ID: 7511251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro studies of the effect of vasoconstrictor nose drops on ciliary epithelium of human nasal mucosa].
    Hofmann T; Wolf G; Koidl B
    Laryngorhinootologie; 1995 Sep; 74(9):564-7. PubMed ID: 7495440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits.
    Suh SH; Chon KM; Min YG; Jeong CH; Hong SH
    Acta Otolaryngol; 1995 Sep; 115(5):664-71. PubMed ID: 8928640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new nasal decongestant, A-57219: a comparison with oxymetazoline.
    DeBernardis JF; Winn M; Kerkman DJ; Kyncl JJ; Buckner S; Horrom B
    J Pharm Pharmacol; 1987 Sep; 39(9):760-3. PubMed ID: 2445950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of a synthetic prostaglandin and xylometazoline hydrochloride as nasal decongestants.
    Jackson RT; Birnbaum JE
    Otolaryngol Head Neck Surg; 1982; 90(5):595-7. PubMed ID: 6186975
    [No Abstract]   [Full Text] [Related]  

  • 9. Paranasal sinusitis after long-term use of topical nasal decongestants.
    Min YG; Kim HS; Suh SH; Jeon SY; Son YI; Yoon S
    Acta Otolaryngol; 1996 May; 116(3):465-71. PubMed ID: 8790749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method for evaluation of action of beta-stimulating and beta-blocking agents on nasal mucous membrane in the rat. A method for investigation of nasal decongestive.
    Stern P; Stern M; Buljubasić S
    Arzneimittelforschung; 1974 Jan; 24(1):70-1. PubMed ID: 4131802
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa.
    Browning S; Housley D; Richards R; Eccles R
    Acta Otolaryngol; 1997 Nov; 117(6):851-5. PubMed ID: 9442826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nose drops induce vasomotion in the microcirculation of the sinus mucosa of the rabbit.
    Bende M; Arfors KE; Intaglietta M
    ORL J Otorhinolaryngol Relat Spec; 1993; 55(2):110-3. PubMed ID: 7680443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of decongestive nosedrops on human respiratory mucosa in vitro.
    Berg OH; Lie K; Steinsvåg SK
    Laryngoscope; 1994 Sep; 104(9):1153-8. PubMed ID: 7520965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new experimental method for evaluating drugs in the nasal cavity.
    Salem H; Clemente E
    Arch Otolaryngol; 1972 Dec; 96(6):524-9. PubMed ID: 4143669
    [No Abstract]   [Full Text] [Related]  

  • 15. The absence of cocaine- and 6-hydroxydopamine-induced supersensitivity to oxymetazoline in the rat anococcygeus muscle.
    Gibson A; Pollock D
    Br J Pharmacol; 1973 Dec; 49(4):726-7. PubMed ID: 4132654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nasal airways response in normal subjects to oxymetazoline spray: randomized double-blind placebo-controlled trial.
    Bickford L; Shakib S; Taverner D
    Br J Clin Pharmacol; 1999 Jul; 48(1):53-6. PubMed ID: 10383560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rhinomanometric tests of the effect of nasivinettes in normal subjects (author's transl)].
    Ey W; Skevas A
    Laryngol Rhinol Otol (Stuttg); 1974 Mar; 53(5):352-7. PubMed ID: 4136431
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Interaction between indomethacin, oxymetazoline and phentolamine on the release of (3H)noradrenaline from brain slices.
    Starke K; Montel H
    J Pharm Pharmacol; 1973 Sep; 25(9):758-9. PubMed ID: 4128174
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with the vasoconstrictor action of H 1032 on the nasal mucosa].
    Carta F
    Arch Ital Otol Rinol Laringol Patol Cervicofacc; 1967; 78(4):510-9. PubMed ID: 4180004
    [No Abstract]   [Full Text] [Related]  

  • 20. Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline.
    Haenisch B; Walstab J; Herberhold S; Bootz F; Tschaikin M; Ramseger R; Bönisch H
    Fundam Clin Pharmacol; 2010 Dec; 24(6):729-39. PubMed ID: 20030735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.